Neuroprotective Effects of Regulators of the Glycogen Synthase Kinase-3β Signaling Pathway in a Transgenic Model of Alzheimer's Disease Are Associated with Reduced Amyloid Precursor Protein Phosphorylation
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
The glycogen synthase kinase-3β (GSK3β) pathway plays an important role in mediating neuronal fate and synaptic plasticity. In Alzheimer's disease (AD), abnormal activation of this pathway might play an important role in neurodegeneration, and compounds such as lithium that modulate GSK3β activity have been shown to reduce amyloid production and tau phosphorylation in amyloid precursor protein (APP) transgenic (tg) mice. However, it is unclear whether regulation of GSK3β is neuroprotective in APP tg mice. In this context, the main objective of the present study was to determine whether pharmacological or genetic manipulations that block the GSK3β pathway might ameliorate the neurodegenerative alterations in APP tg mice and to better understand the mechanisms involved. For this purpose, two sets of experiments were performed. First, tg mice expressing mutant human APP under the Thy1 promoter (hAPP tg) were treated with either lithium chloride or saline alone. Second, hAPP tg mice were crossed with GSK3β tg mice, in which overexpression of this signaling molecule results in a dominant-negative (DN) effect with inhibition of activity. hAPP tg mice that were treated with lithium or that were crossed with DN–GSK3β tg mice displayed improved performance in the water maze, preservation of the dendritic structure in the frontal cortex and hippocampus, and decreased tau phosphorylation. Moreover, reduced activation of GSK3β was associated with decreased levels of APP phosphorylation that resulted in decreased amyloid-β production. In conclusion, the present study showed that modulation of the GSK3β signaling pathway might also have neuroprotective effects in tg mice by regulating APP maturation and processing and further supports the notion that GSK3β might be a suitable target for the treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghribi, O., Herman, M. M., Spaulding, N. K., & Savory, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00957.x · Cited by 94
RetractedInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 4×
“…studies support the possibility that lithium regulates the PI3K– Akt pathway (Klein and Melton, 1996; Chalecka-Franaszek and Chuang, 1999; Mora et al., 1999; Takahashi et al., 1999; Bhat et al., 2000; Elyaman et al., 2002; Mai et al., 2002), which is directly upstream of GSK3 (Cross et al., 1995).”
BackgroundInfluentialSynapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 2×
“The neurodegenerative process in AD consists of synaptic injury (DeKosky and Scheff, 1990; DeKosky et al., 1996; Masliah et al., 1997; Scheff and Price, 2003) and neuronal loss (Terry et al.”
BackgroundA molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 1×
“The FITC-labeled sections were imaged with the LSCM as described previously (Mucke et al., 2000).”
MethodSelf-citationGSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040
Sutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903 · cited 2×
“This observation is also consistent with previous studies showing that trophic factors such as fibroblast growth factor-1 promote GSK3 inactivation via Akt-mediated phosphorylation at Ser9 (Sutherland et al., 1993; Hashimoto et al., 2002), thereby facilitating -catenin nuclear localization (Bienz, 1999) and cell survi…”
BackgroundResultLucas, J. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.27 · Cited by 900
Some morphometric aspects of the brain in senile dementia of the alzheimer type
Terry, R. D., Peck, A., DeTeresa, R., Schechter, R., & Horoupian, D. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100209 · Cited by 801
Cell Biology of the Amyloid beta-Protein Precursor and the Mechanism of Alzheimer's Disease
Selkoe, D. J. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002105 · Cited by 747
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · cited 7×
“Moreover, lithium and valproic acid have been shown to decrease tau phosphorylation in tau tg mice (Nakashima et al., 2005; Noble et al., 2005).”
BackgroundMethodResultInfluentialToggas, S. M., Masliah, E., Rockenstein, E. M., Rail, G. F., Abraham, C. R., & Mucke, L. (1994) · Nature · doi:10.1038/367188a0 · Cited by 682
Self-citationAlzheimer disease and cerebrovascular pathology: an update
Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680 · cited 2×
“…throughout the association cortex and limbic system (Hof and Morrison, 1994), deposition of amyloid- protein (A ) in the neuropil (Jellinger and Bancher, 1998) and around blood vessels (Jellinger, 2002), and formation of intraneuronal neurofibrillary tangles (NFTs) (Trojanowski and Lee, 2000).”
BackgroundA common mechanism of action for three mood-stabilizing drugs
Williams, R. S. B., Cheng, L., Mudge, A. W., & Harwood, A. J. (2002) · Nature · doi:10.1038/417292a · Cited by 618
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600633 · Cited by 594 · cited 1×
“The IP samples were then treated with 100 mU/ml PP1 (Calbiochem), which specifically dephosphorylates GSK3 , for 30 min at 30°C essentially as described previously (McManus et al., 2005).”
MethodChalecka-Franaszek, E., & Chuang, D.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 542
Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau
Mandelkow, E.-M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J. R., & Mandelkow, E. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81496-9 · Cited by 515 · cited 2×
“Among them, considerable attention has been dedicated to the role of GSK3 on tau phosphorylation and the formation of tangles (Mandelkow et al., 1992; Baum et al., 1996; Pei et al., 1999; Ishizawa et al., 2003).”
BackgroundRockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C. W., Lang, I., & Masliah, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10231 · Cited by 502 · cited 3×
“To eval- uate the effects of GSK3 inhibition on amyloid plaque load and tau phosphorylation, briefly as described previously (Rockenstein et al., 2002a), vibratome sections were incubated overnight at 4°C with the mouse monoclonal antibody 6E10 (1:1000; Signet Laboratories), which specifically…”
MethodSelf-citationLithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium
Ryves, W. J., & Harwood, A. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4169 · Cited by 493
Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression
Chen, R.-W., & Chuang, D.-M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6039 · Cited by 469
Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199909000-00011 · Cited by 459
APP processing is regulated by cytoplasmic phosphorylation
Lee, M.-S., Kao, S.-C., Lemere, C. A., Xia, W., Tseng, H.-C., Zhou, Y., Neve, R., Ahlijanian, M. K., & Tsai, L.-H. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200301115 · Cited by 454
Nonaka, S., Hough, C. J., & Chuang, D.-M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2642 · Cited by 427
Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9637 · Cited by 409
Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change
DeKosky, S. T., Scheff, S. W., & Styren, S. D. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0056 · Cited by 405
Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies
Scheff, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.002 · Cited by 391
Spittaels, K., Van den Haute, C., Van Dorpe, J., Bruynseels, K., Vandezande, K., Laenen, I., Geerts, H., Mercken, M., Sciot, R., Van Lommel, A., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65533-2 · Cited by 385
Hernández, F., Borrell, J., Guaza, C., Avila, J., & Lucas, J. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01269.x · Cited by 372
Distribution, Levels, and Activity of Glycogen Synthase Kinase-3 in the Alzheimer Disease Brain
PEI, J.-J., TANAKA, T., TUNG, Y.-C., BRAAK, E., IQBAL, K., & GRUNDKE-IQBAL, I. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199701000-00007 · Cited by 371
Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., & Lee, C.-M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190297597 · Cited by 366
Patterns of gliosis in alzheimer's disease and aging cerebrum
Beach, T. G., Walker, R., & McGeer, E. G. (1989) · Glia · doi:10.1002/glia.440020605 · Cited by 336
Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
Manji, H. K., Moore, G. J., & Chen, G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00165-1 · Cited by 313
Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced Apoptosis
Bijur, G. N., De Sarno, P., & Jope, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7583 · Cited by 301
Su, Y., Ryder, J., Li, B., Wu, X., Fox, N., Solenberg, P., Brune, K., Paul, S., Zhou, Y., Liu, F., et al. (2004) · Biochemistry · doi:10.1021/bi035627j · Cited by 296
Baki, L., Shioi, J., Wen, P., Shao, Z., Schwarzman, A., Gama‐Sosa, M., Neve, R., & Robakis, N. K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600251 · Cited by 289
Engel, T., Hernández, F., Avila, J., & Lucas, J. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0604-06.2006 · Cited by 260
Rockenstein, E. M., McConlogue, L., Tan, H., Power, M., Masliah, E., & Mucke, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28257 · Cited by 259
Self-citationNeuroprotective effects of chronic lithium on focal cerebral ischemia in rats
Nonaka, S., & Chuang, D.-M. (1998) · NeuroReport · doi:10.1097/00001756-199806220-00031 · Cited by 249
Glycogen synthase kinase‐3β, mood stabilizers, and neuroprotection
Li, X., Bijur, G. N., & Jope, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.40201.x · Cited by 243
Iijima, K., Ando, K., Takeda, S., Satoh, Y., Seki, T., Itohara, S., Greengard, P., Kirino, Y., Nairn, A. C., & Suzuki, T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751085.x · Cited by 234
Neuropathology of Alzheimer’s disease: a critical update
Jellinger, K. A., & Bancher, C. (1998) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-7508-8_8 · Cited by 231
Rockenstein, E., Mallory, M., Mante, M., Sisk, A., & Masliaha, E. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1247 · Cited by 223
Self-citationThe Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Proteina
SELKOE, D. J., YAMAZAKI, T., CITRON, M., PODLISNY, M. B., KOO, E. H., TEPLOW, D. B., & HAASS, C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34401.x · Cited by 205
Aplin, A. E., Gibb, G. M., Jacobsen, J. S., Gallo, J., & Anderton, B. H. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020699.x · Cited by 201 · cited 3×
“…e Silva, 2003; Lee et al., 2003) and GSK3 [as well as stress-activated protein kinase (SAPK) and cyclindependent kinase-5 (CDK5)] plays a role in this process (Aplin et al., 1996; Iijima et al., 2000; Ryder et al., 2003), immunoblot analysis was performed with an antibody against APP-p (Thr668).”
BackgroundBDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents
Mai, L., Jope, R. S., & Li, X. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00939.x · Cited by 195
The GSK3β signaling cascade and neurodegenerative disease
Kaytor, M. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00320-3 · Cited by 195
Notch signalling pathway and human diseases
Joutel">, A., & Tournier-Lasserve, E. (1998) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.1998.0261 · Cited by 188
TROJANOWSKI, J. Q., & LEE, V. M. ‐. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05561.x · Cited by 185
Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model
Pérez, M., Hernández, F., Lim, F., Díaz-Nido, J., & Avila, J. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5405 · Cited by 180
Ozaki, N., & Chuang, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062336.x · Cited by 179
5 Cellular Mechanisms of Wingless/Wnt Signal Transduction
Dierick, H., & Bejsovec, A. (1998) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)60381-6 · Cited by 175
O’Donnell, T., Rotzinger, S., Nakashima, T. T., Hanstock, C. C., Ulrich, M., & Silverstone, P. H. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02797-9 · Cited by 175
Divergent roles of GSK3 and CDK5 in APP processing
Ryder, J. W., Yuan, S., Liu, F., Li, B., Zhou, Y., & Ni, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.014 · Cited by 143
BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo
Lee, E. B., Zhang, B., Liu, K., Greenbaum, E. A., Doms, R. W., Trojanowski, J. Q., & Lee, V. M.-Y. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407070 · Cited by 140
Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s disease
Wei, H., Qin, Z.-H., Senatorov, V. V., Wei, W., Wang, Y., Qian, Y., & Chuang, D.-M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00311-6 · Cited by 137
Nakashima, H., Ishihara, T., Suguimoto, S. P., Yokota, O., Oshima, E., Kugo, A., Terada, S., Hamamura, T., Trojanowski, J. Q., Lee, V. M. ‐., et al. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1087-4 · Cited by 129
Role of Phosphorylation of Alzheimer’s Amyloid Precursor Protein during Neuronal Differentiation
Ando, K., Oishi, M., Takeda, S., Iijima, K.-I., Isohara, T., Nairn, A. C., Kirino, Y., Greengard, P., & Suzuki, T. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04421.1999 · Cited by 128
Fibroblast Growth Factor 1 Regulates Signaling via the Glycogen Synthase Kinase-3β Pathway
Hashimoto, M., Sagara, Y., Langford, D., Everall, I. P., Mallory, M., Everson, A., Digicaylioglu, M., & Masliah, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202803200 · Cited by 127
Self-citationImmunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease
Masliah, E., Mallory, M., Hansen, L., Alford, M., Albright, T., Terry, R., Shapiro, P., Sundsmo, M., & Saitoh, T. (1991) · Acta Neuropathologica · doi:10.1007/bf00294425 · Cited by 112 · cited 2×
“, 1989) and microglial cell proliferation (Rogers et al., 1988; Masliah et al., 1991).”
BackgroundSelf-citationLithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A
Mora, A., Sabio, G., Risco, A. M., Cuenda, A., Alonso, J. C., Soler, G., & Centeno, F. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00282-0 · Cited by 111
Bienz, M. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00016-7 · Cited by 108
Ryder, J. W., Yuan, S., & Ni, B. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.07.004 · Cited by 107
Lithium Ameliorates HIV-gp120-Mediated Neurotoxicity
Everall, I. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1196 · Cited by 105
Different mechanisms of protection against apoptosis by valproate and Li+
Mora, A., González‐Polo, R. A., Fuentes, J. M., Soler, G., & Centeno, F. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00919.x · Cited by 101
Ishizawa, T., Sahara, N., Ishiguro, K., Kersh, J. S., McGowan, E. M., Lewis, J. M., Hutton, M. L., Dickson, D. W., & Yen, S.-H. C. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63465-7 · Cited by 100
Takahashi, M., Yasutake, K., & Tomizawa, K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02073.x · Cited by 100
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes
Brownlees, J., Irving, N. G., Brion, J.-P., M. Gibb, B. J., Wagner, U., Woodgett, J., & J. Miller, C. C. (1997) · NeuroReport · doi:10.1097/00001756-199710200-00013 · Cited by 99
Sites of phosphorylation in tau and factors affecting their regulation
Anderton, B. H., Betts, J., Blackstock, W. P., Brion, J.-P., Chapman, S., Connell, J., Dayanandan, R., Gallo, J.-M., Gibb, G., Hanger, D. P., et al. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670073 · Cited by 98
Rockenstein, E., Mante, M., Alford, M., Adame, A., Crews, L., Hashimoto, M., Esposito, L., Mucke, L., & Masliah, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507016200 · Cited by 95
Self-citationRockenstein, E., Schwach, G., Ingolic, E., Adame, A., Crews, L., Mante, M., Pfragner, R., Schreiner, E., Windisch, M., & Masliah, E. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20446 · Cited by 90
Self-citationMucke, L., Abraham, C. R., Ruppe, M. D., Rockenstein, E. M., Toggas, S. M., Mallory, M., Alford, M., & Masliah, E. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1551 · Cited by 88
Self-citationShaw, M., & Cohen, P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01434-9 · Cited by 88
Takahashi, M., Yasutake, K., & Tomizawa, K. (1999) · PubMed · Cited by 88
Rockenstein, E. M., Adame, A., Mante, M., Moessler, H., Windisch, M., & Masliah, E. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0025-7 · Cited by 86
Self-citationBaum, L., Hansen, L. A., Masliah, E., & Saitoh, T. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815006 · Cited by 81
Self-citationElyaman, W., Terro, F., Wong, N. S., & Hugon, J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01899.x · Cited by 79
Protein Phosphorylation and APP Metabolism
Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2003) · Neurochemical Research · doi:10.1023/a:1025630627319 · Cited by 78
Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology
Shiurba, R., Ishiguro, K., Takahashi, M., Sato, K., Spooner, E. T., Mercken, M. H., Yoshida, R. Y., Wheelock, T. R., Yanagawa, H., Imahori, K., et al. (1996) · Brain Research · doi:10.1016/0006-8993(96)00717-2 · Cited by 74
Lithium Activates the c‐Jun NH2‐Terminal Kinases In Vitro and in the CNS In Vivo
Yuan, P., Chen, G., & Manji, H. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732299.x · Cited by 69
Torres, M. A., Eldar-Finkelman, H., Krebs, E. G., & Moon, R. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1427 · Cited by 66
Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.
Rockenstein, E. M., Mallory, M. E., Mante, M., Alford, M. F., Windisch, M., Moessler, H., & Masliah, E. (2002) · PubMed · Cited by 48
Self-citationEffects of Cerebrolysin™ on amyloid-β deposition in a transgenic model of Alzheimer’s disease
Rockenstein, E. M., Mallory, M. E., Mante, M., Alford, M. F., Windisch, M., Moessler, H., & Masliah, E. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_31 · Cited by 44
Self-citationTanzi, R. E., Wenniger, J. J., & Hyman, B. T. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90196-v · Cited by 37
Molecular Mechanisms of Synaptic Disconnection in Alzheimer’s Disease
Masliah, E., Mallory, M. E., Alford, M. F., DeTeresa, R. M., Iwai, A., & Saitoh, T. (1997) · Springer eBooks · doi:10.1007/978-3-642-60680-9_9 · Cited by 22
Self-citationGlycogen synthase kinase 3α and 3β do not colocalize with neurofibrillary tangles
Harr, S. D., Hollister, R. D., & Hyman, B. T. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00025-5 · Cited by 18
Cited by
The GSK3 hypothesis of Alzheimer’s disease
Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Crews, L., & Masliah, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq160 · Cited by 772
Self-citationAnimal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676
GSK-3β, a pivotal kinase in Alzheimer disease
Llorens-MarÃtin, M., Jurado, J., Hernández, F., & Ãvila, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00046 · Cited by 451
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
Brunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2959 · Cited by 440
“79 ) and GSK3 have been implicated in the upregulation of Aβ synthesis, with inhibition of GSK3α and GSK3β reported to decrease Aβ level”
Background
Metadata
- Authors
- Rockenstein, E., Torrance, M., Adame, A., Mante, M., Bar-on, P., Rose, J. B., Crews, L., & Masliah, E.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-02-21
- Volume
- 27
- Issue
- 8
- Pages
- 1981-1991
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1996499871
- Cited by
- 288
- References
- 88
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.